Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer – Newswise (press release)
Fox News |
Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer
Newswise (press release) By combining chemotherapy with immunotherapy in this clinical trial, we are extending our options for treatment, and finding new hope,” said Dr. Pusztai. The phase I part of the trial sought to determine the safety and tolerability of durvalumab in … As scientists train the immune system to fight cancer, others look to combat costs |
